Journal for ImmunoTherapy of Cancer (Jun 2022)
Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186
- Ying Zhu,
- Danielle E Dettling,
- Eilene Kwok,
- Lucy Quach,
- Aakash Datt,
- Jeremiah D Degenhardt,
- Anand Panchal,
- Pui Seto,
- Jessica L Krakow,
- Russell Wall,
- Brian J Hillier,
- Maia Vinogradova,
- Robert B DuBridge,
- Chad May
Affiliations
- Ying Zhu
- Harvard Retinal Imaging Lab, Boston, Massachusetts, USA
- Danielle E Dettling
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Eilene Kwok
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Lucy Quach
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Aakash Datt
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Jeremiah D Degenhardt
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Anand Panchal
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Pui Seto
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Jessica L Krakow
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Russell Wall
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Brian J Hillier
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Maia Vinogradova
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Robert B DuBridge
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- Chad May
- Oncology Drug Development Unit, Takeda Development Centers America, Inc (TDCA), Lexington, Massachusetts, USA
- DOI
- https://doi.org/10.1136/jitc-2021-004336
- Journal volume & issue
-
Vol. 10,
no. 6
Abstract
No abstracts available.